• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Prognostic factors in pituitary tumors: clinical, biochemical, imaging, and pathological aspects.

作者信息

Tateno Toru, Dumitriu Stan Roxana-Ioana, Du Four Stephanie

机构信息

Department of Medicine, University of Alberta, Edmonton, AB, Canada.

Department of Endocrinology, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.

出版信息

Front Endocrinol (Lausanne). 2024 Oct 23;15:1492448. doi: 10.3389/fendo.2024.1492448. eCollection 2024.

DOI:10.3389/fendo.2024.1492448
PMID:39507053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11538065/
Abstract
摘要

相似文献

1
Editorial: Prognostic factors in pituitary tumors: clinical, biochemical, imaging, and pathological aspects.社论：垂体肿瘤的预后因素：临床、生化、影像学及病理学方面
Front Endocrinol (Lausanne). 2024 Oct 23;15:1492448. doi: 10.3389/fendo.2024.1492448. eCollection 2024.
2
Clinical and Pathological Aspects of Silent Pituitary Adenomas.无症状垂体腺瘤的临床与病理特征。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2473-2489. doi: 10.1210/jc.2018-00688.
3
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.非功能性垂体神经内分泌肿瘤的诊断和治疗的最新证据更新。
Endocrinol Metab (Seoul). 2023 Dec;38(6):631-654. doi: 10.3803/EnM.2023.1838. Epub 2023 Nov 15.
4
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.泌乳素垂体瘤的预后因素：来自 94 例长期术后随访患者的临床、组织学和分子数据。
J Clin Endocrinol Metab. 2010 Apr;95(4):1708-16. doi: 10.1210/jc.2009-1191. Epub 2010 Feb 17.
5
Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors.侵袭性垂体肿瘤或局限性垂体癌：垂体肿瘤的定义
Expert Rev Endocrinol Metab. 2016 Mar;11(2):149-162. doi: 10.1586/17446651.2016.1153422.
6
Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.囊性与非囊性无功能性促肾上腺皮质腺瘤：经蝶显微手术治疗 62 例回顾性单中心研究——临床与组织学分析
Sci Rep. 2023 Feb 11;13(1):2468. doi: 10.1038/s41598-023-29628-3.
7
In search of a prognostic classification of endocrine pituitary tumors.寻找垂体内分泌肿瘤的预后分类。
Endocr Pathol. 2014 Jun;25(2):124-32. doi: 10.1007/s12022-014-9322-y.
8
Thyroid-stimulating hormone pituitary adenomas.促甲状腺激素垂体腺瘤
J Neurosurg. 2008 Jul;109(1):17-22. doi: 10.3171/JNS/2008/109/7/0017.
9
Incidence and Prognostic Factors of Patients with Benign Pituitary Tumors Based on the Surveillance, Epidemiology, and End Results (SEER) Database.基于监测、流行病学和最终结果（SEER）数据库的良性垂体瘤患者的发病率和预后因素。
World Neurosurg. 2022 Sep;165:e30-e42. doi: 10.1016/j.wneu.2022.04.113. Epub 2022 Apr 30.
10
[Molecular Mechanisms of Pituitary Tumorigenesis].[垂体肿瘤发生的分子机制]
No Shinkei Geka. 2023 Jul;51(4):615-623. doi: 10.11477/mf.1436204794.

本文引用的文献

1
Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma.多激素垂体腺瘤的发病机制、临床特征及治疗
Front Neurosci. 2024 Jan 8;17:1323883. doi: 10.3389/fnins.2023.1323883. eCollection 2023.
2
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.非功能性垂体神经内分泌肿瘤的诊断和治疗的最新证据更新。
Endocrinol Metab (Seoul). 2023 Dec;38(6):631-654. doi: 10.3803/EnM.2023.1838. Epub 2023 Nov 15.
3
[Plurihormonal PIT1-lineage pituitary neuroendocrine tumors: a clinicopathological study].[多激素PIT1谱系垂体神经内分泌肿瘤：一项临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2023 Oct 8;52(10):1017-1024. doi: 10.3760/cma.j.cn112151-20230216-00137.
4
Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors.侵袭性垂体瘤的多模态非手术治疗。
Front Endocrinol (Lausanne). 2021 Mar 26;12:624686. doi: 10.3389/fendo.2021.624686. eCollection 2021.
5
Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal.内镜切除无功能垂体腺瘤后手术效果改善的证据。
Neurosurg Focus. 2011 Apr;30(4):E11. doi: 10.3171/2011.1.FOCUS10308.
6
The prevalence of pituitary adenomas: a systematic review.垂体腺瘤的患病率：一项系统综述。
Cancer. 2004 Aug 1;101(3):613-9. doi: 10.1002/cncr.20412.
7
Incidence, etiology, and management of cerebrospinal fluid leaks following trans-sphenoidal surgery.经蝶窦手术后脑脊液漏的发生率、病因及处理
Laryngoscope. 2003 Aug;113(8):1283-8. doi: 10.1097/00005537-200308000-00003.
8
Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas.与垂体腺瘤经鼻内镜经蝶窦入路相关的手术并发症。
J Neurosurg. 2002 Aug;97(2):293-8. doi: 10.3171/jns.2002.97.2.0293.